A comprehensive review on the carcinogenic potential of bisphenol A: clues and evidence

NG Khan, J Correia, D Adiga, PS Rai… - … Science and Pollution …, 2021 - Springer
Abstract Bisphenol A [BPA;(CH 3) 2 C (C 6 H 4 OH) 2] is a synthetic chemical used as a
precursor material for the manufacturing of plastics and resins. It gained attention due to its …

[HTML][HTML] Therapeutic options for mucinous ovarian carcinoma

KL Gorringe, D Cheasley, MJ Wakefield, GL Ryland… - Gynecologic …, 2020 - Elsevier
Objective Mucinous ovarian carcinoma (MOC) is an uncommon ovarian cancer histotype
that responds poorly to conventional chemotherapy regimens. Although long overall survival …

Estrone-conjugated PEGylated liposome Co-loaded paclitaxel and carboplatin improve anti-tumor efficacy in ovarian cancer and reduce acute toxicity of chemo-drugs

H Tang, Y Xie, M Zhu, J Jia, R Liu, Y Shen… - International Journal …, 2022 - Taylor & Francis
Purpose Ovarian cancer is the most lethal gynecologic malignancy. The combination of
paclitaxel (PTX) and carboplatin (CBP) is the first-line remedy for clinical ovarian cancer …

Effects of the Overexpression of Progesterone Receptors on a Precancer p53 and Rb-Defective Human Fallopian Tube Epithelial Cell Line

YH Chang, KC Wu, KH Wang, DC Ding - International Journal of …, 2023 - mdpi.com
This study investigated the effects of progesterone receptors A (PRA) and B (PRB) on
proliferation, migration, invasion, anchorage-independent growth (AIG), and apoptosis of …

BRCA1 Protein Expression in Epithelial Ovarian Cancer and Associated Clinicopathological Factors in Uganda

T Okecha, DB Abila, DL Nabbale… - Obstetrics and …, 2024 - Wiley Online Library
Background: BRCA1 gene dysfunction seen in epithelial ovarian carcinomas often results
from germline mutations, somatic mutations, and promoter methylation. Identification of …

Prognostic value of β-Arrestins in combination with glucocorticoid receptor in epithelial ovarian cancer

JW Ryu, HY Shin, HS Kim, GH Han, JW Kim… - Frontiers in …, 2023 - frontiersin.org
Hormones may be key factors driving cancer development, and epidemiological findings
suggest that steroid hormones play a crucial role in ovarian tumorigenesis. We …

Assessing the predictive response of a simple and sensitive blood-based biomarker between estrogen-negative solid tumors

S Mohan, S Patel, D Barlow, AC Rojas - Advances in Medical Sciences, 2020 - Elsevier
Purpose We investigated N w-hydroxy l-Arginine (NOHA) predictive response in serous
ovarian carcinoma based on estrogen-hormone receptor expression status; and assessed …

Etablierung und Überprüfung eines Biomarkerpanels zum besseren Karzinogeneseverständnis, sichereren Diagnostik und möglichen Graduierung der muzinösen …

EM Holley - 2023 - edoc.ub.uni-muenchen.de
In der pathologischen Diagnostik ist eine Abgrenzung zwischen primären muzinösen
Ovarialkarzinomen und ovariellen Metastasen mit Ursprung in Kolon, Zervix, Pankreas und …

[PDF][PDF] Expression of Estrogen and Progesterone Receptors in Primary Epithelial Ovarian Malignancies Seen at the Jos University Teaching Hospital

TN Fadok, I Emmanuel, PO Akpa, AN Manasseh… - 2023 - oldsite.jbrcp.org
University Teaching Hospital between the 1 January 2004 and 31 December, 2013.
Methods: This was a hospital based retrospective study of ovarian surface epithelial …

Expression of Estrogen receptor (ER), Progesterone receptor (PR), Her2/neu in various types of Epithelial Ovarian Tumors

F Ameli, M Entezarian, N Masir, TG Chin - Journal of Obstetrics …, 2024 - jogcr.com
Background & Objective: The highest mortality rate in gynecologic cancers is attributed to
ovarian origin. Expression of the estrogen and progesterone receptors (ER and PR); and …